Skip to Content

Seysara Approval History

FDA Approved: Yes (First approved October 1, 2018)
Brand name: Seysara
Generic name: sarecycline
Dosage form: Tablets
Company: Almirall, LLC
Treatment for: Acne

Seysara (sarecycline) is an oral, narrow spectrum tetracycline-derived antibiotic for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.

Development History and FDA Approval Process for Seysara

DateArticle
Oct  2, 2018Approval FDA Approves Seysara (sarecycline) for the Treatment of Moderate to Severe Acne
Dec 20, 2017FDA Accepts New Drug Application for Seysara (sarecycline) for the Treatment of Moderate to Severe Acne
Mar 27, 2017Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide